| Offering Information |
| Expected Date | TBA |
| Proposed Exchange/Ticker |
Nasdaq: ALIM |
| Security Type |
Common Stock |
| Lead Underwriter |
Credit Suisse Citi |
| Days In Registration |
- |
| Date Filed |
1-Jul-2008 |
| Form Filed | S-1 |
Fundamentals
(Year Ending December 2007) |
| Industry |
Manufacturing |
| Business Description |
Alimera Sciences Inc, located in Alpharetta, Georgia, manufactures pharmaceuticals specializing in the development and commercialization of over-the-counter and prescription ophthalmology pharmaceuticals. It is a Delaware corporation incorporated on June 4, 2003. |
| Revenue |
- |
| Net Income |
- |
| Shares Outstanding (post-offering) |
- |
| Contact |
- |
| Number of Employees |
7 |
|
| Original Filing Information |
| US |
| Shares Filed |
- |
| Secondary Shares Filed | - |
| · As a Percent |
- |
| Primary Shares Filed |
- |
| · As a Percent |
- |
| Overallotment Shares Filed |
- |
| File Amount |
$75.0M |
| File Price Range |
- - - |
| File Mid Price |
- |
|
